[1] |
|
[2] |
Ahn SY, Chang YS, Kim JH, et al. Two-year follow-up outcomes of premature infants enrolled in the phase Ⅰ trial of mesenchymal stem cells transplantation for bronchopulmonary dysplasia[J]. J Pediatr, 2017, 185: 49-54.e2. DOI: 10.1016/j.jpeds.2017.02.061.
|
[3] |
Hassanein SM, Nasr Eldin MH, Amer HA, et al. Human umbilical cord blood CD34-positive cells as predictors of the incidence and short-term outcome of neonatal hypoxic-ischemic encephalopathy: a pilot study[J]. J Clin Neurol, 2017, 13(1): 84-90. DOI: 10.3988/jcn.2017.13.1.84.
|
[4] |
Pimentel-Coelho PM, Rosado-de-Castro PH, da Fonseca LM, et al. Umbilical cord blood mononuclear cell transplantation for neonatal hypoxic-ischemic encephalopathy[J]. Pediatr Res, 2012, 71(4 Pt 2): 464-473. DOI: 10.1038/pr.2011.59.
|
[5] |
|
[6] |
邵肖梅,叶鸿瑁,邱小汕. 实用新生儿学[M]. 4版. 北京:人民卫生出版社,2011: 416-422.
|
[7] |
Chang YS, Ahn SY, Yoo HS, et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial[J]. J Pediatr, 2014, 164(5): 966-972.e6. DOI: 10.1016/j.jpeds.2013.12.011.
|
[8] |
Albano MS, Taylor P, Pass RF, et al. Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening[J]. Blood, 2006, 108(13): 4275-4282. DOI: 10.1182/blood-2006-04-020313.
|
[9] |
Albano MS, Ciubotariu R, Dobrila L, et al. Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency[J]. Transfusion, 2017, 57(11): 2768-2774. DOI: 10.1111/trf.14257.
|
[10] |
Lee JH, Kwon BS, Ha IS, et al. Nephrotic syndrome in a child after umbilical-cord-blood transplantation[J]. Pediatr Nephrol, 2006, 21(9): 1312-1317. DOI: 10.1007/s00467-006-0171-x.
|
[11] |
Radhi M, Rumelhart S, Tatman D, et al. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab[J]. J Pediatr Hematol Oncol, 2007, 29(2): 125-127. DOI: 10.1097/MPH.0b013e3180320b23.
|
[12] |
Mullen CA, Thompson JN, Richard LA, et al. Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type ⅡB (Hunter syndrome) complicated by autoimmune hemolytic anemia[J]. Bone Marrow Transplant, 2000, 25(10): 1093-1097. DOI: 10.1038/sj.bmt.1702397.
|
[13] |
Page KM, Mendizabal AM, Prasad VK, et al. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation[J]. Biol Blood Marrow Transplant, 2008, 14(10): 1108-1117. DOI: 10.1016/j.bbmt.2008.07.006.
|
[14] |
Dovat S, Roberts RL, Wakim M, et al. Immune thrombocytopenia after umbilical cord progenitor cell transplant: response to vincristine[J]. Bone Marrow Transplant, 1999, 24(3): 321-323. DOI: 10.1038/sj.bmt.1701888.
|
[15] |
Jillella AP, Kallab AM, Kutlar A. Autoimmune thrombocytopenia following autologous hematopoietic cell transplantation: review of literature and treatment options[J]. Bone Marrow Transplant, 2000, 26(8): 925-927. DOI: 10.1038/sj.bmt.1702658.
|
[16] |
|
[17] |
|
[18] |
Sevilla J, González-Vicent M, Madero L, et al. Acute autoimmune hemolytic anemia following unrelated cord blood transplantation as an early manifestation of chronic graft-versus-host disease[J]. Bone Marrow Transplant, 2001, 28(1): 89-92. DOI: 10.1038/sj.bmt.1703087.
|
[19] |
Kang M, Thébaud B. Stem cell biology and regenerative medicine for neonatal lung diseases[J]. Pediatr Res, 2018, 83(1-2): 291-297. DOI: 10.1038/pr.2017.232.
|
[20] |
Guz K, Uhrynowska M, Kopeć I, et al. Recent advances in understanding the clinical relevance of antiplatelet alloantibodies[J]. Pol Arch Intern Med, 2017, 127(3): 190-194. DOI: 10.20452/pamw.3932.
|
[21] |
Broxmeyer HE. Questions to be answered regarding umbilical cord blood hematopoietic stem and progenitor cells and their use in-transplantation[J]. Transfusion, 1995, 35(8): 694-702. DOI: 10.1046/j.1537-2995.1995.35895357903.x.
|
[22] |
Lazaryan A, Weisdorf DJ, DeFor T, et al. Risk factors for acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation with umbilical cord blood and matched sibling donors[J]. Biol Blood Marrow Transplant, 2016, 22(1): 134-140. DOI: 10.1016/j.bbmt.2015.09.008.
|
[23] |
Uchino M, Ogawa Y, Kawai M, et al. Ocular complications in a child with acute graft-versus-host disease following cord blood stem cell transplantation: therapeutic challenges[J]. Acta Ophthalmol Scand, 2006, 84(4): 545-548. DOI: 10.1111/j.1600-0420.2006.00658.x.
|
[24] |
|